It is particularly relevant to include inflammatory and functional biomarkers (such as CRP, IL-6, MIS, or PINI) as secondary endpoints to better characterise the malnutrition–inflammation complex and its response to therapy. This evidence concerns the gene CRP and nutritional deficiency disease.